NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/26/2025
Back to search
Official data from USPTO
ASD - HIPROS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ASD - HIPROS
ST13
US500000079331573Class
5, 42
Filing
79331573
Registration
6932819
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/27/2025
Trademark type
Word
Nice classes
5, 42
Filing date
05/07/2021
Registration date
12/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/27/2022
Last transaction
06/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
77
Owner location
IE
Examiner
KUYKENDALL, LYNDSEY
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hovione Scientia Limited
Representatives
R Peter Spies DTL, Ltd
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Active pharmaceutical ingredients in the nature of pharmaceutical preparationswhich are used for the prevention and treatment of disorders of the skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systems of humans or animals; compositions for medical and veterinarian usechemical products for pharmaceutical usechemical preparations for the preventiondiagnosistreatment or improvement of conditions and disordersinflammatoryallergicaloncologicaldegenerativegenetictraumatictumouralpressurepoisoningmutationsepsispsychiatricobeseeatingaddictivesexualsleepinfectious conditions and disordersbacterialviralfungal or parasitic conditions and disordersall of the above related to skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systemsas well as pain managementfor use by humans or animals; medical diagnostic compositionsnamely medical diagnostic reagents; chemical products for pharmaceutical usechemical preparations for the preventiondiagnosistreatment or improvement of conditions and disordersinflammatoryallergicaloncologicaldegenerativegenetictraumatictumouralpressurepoisoningmutationsepsispsychiatricobeseeatingaddictivesexualsleepinfectious conditions and disordersbacterialviralfungal or parasitic conditions and disordersall of the above related to skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systemsas well as pain managementfor use by humans or animals
Class 42
Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research in the field of optimizing of manufacturing processes for the pharmaceutical industry
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/10/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/14/2023
FIMP
FINAL DISPOSITION PROCESSED
04/13/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/27/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2022
PUBO
PUBLISHED FOR OPPOSITION
10/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/10/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/21/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/21/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2022
RFNT
REFUSAL PROCESSED BY IB
03/22/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/28/2022
RFRR
REFUSAL PROCESSED BY MPU
02/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/29/2022
CNRT
NON-FINAL ACTION WRITTEN
01/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/25/2022
DOCK
ASSIGNED TO EXAMINER
01/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/20/2022
Continuous trademark protection
Get notified about every new filing that threatens ASD - HIPROS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.